You are here

Padcev

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity

Benzinga

Mon, 09/9/24 - 10:49 am

Bicycle Therapeutics

metastatic urothelial cancer

3 Big Pharma cancer drugs facing inflation penalties

Pharma Voice

Wed, 07/31/24 - 10:27 am

Inflation Reduction Act

Bristol Myers Squibb

Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Clinical Trials Arena

Thu, 03/21/24 - 06:41 pm

urothelial cancer

Bristol Myers Squibb

Astellas' sales expectations are up for Padcev, down for Veozah

Fierce Pharma

Mon, 02/5/24 - 11:02 pm

Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer

Fierce Pharma

Tue, 12/19/23 - 10:26 am

FDA starts review of Padcev/Keytruda for bladder cancer

Pharmaphorum

Fri, 12/1/23 - 09:35 am

priority review

Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO

BioSpace

Mon, 10/23/23 - 05:15 pm

Bristol Myers Squibb

PD-1 inhibitors

ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow

Fierce Pharma

Sun, 10/22/23 - 06:06 pm

Bristol Myers Squibb

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer

Fierce Pharma

Wed, 10/18/23 - 11:42 am

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

BioSpace

Fri, 09/22/23 - 11:53 am

urothelial cancer

clinical trials

FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer

BioSpace

Tue, 04/4/23 - 12:35 pm

metastatic urothelial carcinoma

ASCO-GU – Bicycle tries to put distance between itself and Seagen

EP Vantage

Thu, 02/16/23 - 10:15 am

Bicycle Therapeutics

urothelial cancer

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev

Fierce Biotech

Mon, 02/13/23 - 10:29 am

Corbus Pharmaceuticals

ESMO: Seagen's Padcev pulls its weight in combo with Merck's Keytruda

Fierce Pharma

Thu, 09/8/22 - 04:40 pm

urothelial cancer

Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Yahoo/Zacks.com

Fri, 08/12/22 - 10:12 am

Seagen, Astellas claim positive results in study key to cancer drug's success

BioPharma Dive

Tue, 07/26/22 - 11:26 am

clinical trials

Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer

Pharmaforum

Mon, 02/14/22 - 11:44 pm

clinical trials

FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro

RAPS.org

Thu, 07/15/21 - 12:34 pm

Teva Pharmaceutical

ArmonAir RespiClick

Darzalex Faspro

Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land

Fierce Pharma

Sat, 07/10/21 - 12:00 am

#ASCO21: Ahead of August PDUFA date, Astellas and Seagen sweeten Padcev pitch with new data

Endpoints

Thu, 05/20/21 - 12:16 pm

urothelial cancer

Pages